CN104998176A - Traditional Chinese medicine composition for treating diabetes - Google Patents
Traditional Chinese medicine composition for treating diabetes Download PDFInfo
- Publication number
- CN104998176A CN104998176A CN201510536398.5A CN201510536398A CN104998176A CN 104998176 A CN104998176 A CN 104998176A CN 201510536398 A CN201510536398 A CN 201510536398A CN 104998176 A CN104998176 A CN 104998176A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- rhizoma
- herba
- chinese medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a traditional Chinese medicine composition for treating diabetes. The traditional Chinese medicine composition comprises the following ingredients in parts by weight: 10 to 15 parts of ginseng, 1 to 40 parts of astragalus membranaceus, 10 to 20 parts of poria cocos, 10 to 20 parts of liquorice, 20 to 30 parts of radix rehmanniae, 10 to 20 parts of trichosanthis, 10 to 20 parts of ophiopogon root, 10 to 20 parts of rhizoma anemarrhenae, 5 to 10 parts of coptis chinensis, 15 to 25 parts of plaster, 10 to 20 parts of cuscuta chinensis, 10 to 20 parts of cistanche deserticola, 10 to 30 parts of semen astragali complanati, 15 to 30 parts of Chinese yam, 15 to 30 parts of fructus corni, 15 to 25 parts of gizzard pepsin, 10 to 20 parts of radix polygonati officinalis, 5 to 15 parts of lucid ganoderma, 10 to 15 parts of dendrobe, 10 to 15 parts of angelica, 10 to 20 parts of barbary wolfberry fruit, 10 to 20 parts of rhizoma atractylodis, 10 to 20 parts of salvia miltiorrhiza, 10 to 20 parts of motherwort, 10 to 20 parts of raspberry, 10 to 20 parts of bitter cardamom, 15 to 25 parts of figwort, 15 to 25 parts of oyster, 15 to 25 parts of sealwort, 15 to 25 parts of semen cassiae and 8 to 12 parts of rheum officinale. The traditional Chinese medicine composition has the advantages that natural traditional Chinese medicine raw materials are used; the medicine sources are wide; the cost is low; the preparation is simple; the toxic and side effects are few; the curative effect is obvious.
Description
Technical field
The present invention relates to field of medicaments, relate in particular to a kind of Chinese medicine composition for the treatment of diabetes.
Background technology
Diabetes is mainly named according to symptom, becomes thin because of thirsty.The symptom of some diseases is had also to be " disappearing because of thirsty ", such as hyperthyroidism, diabetes insipidus etc.Therefore, diabetes can not refer in particular to diabetes.The doctor Tang Dynasty discriminates to expound one's ideas in writing diabetes is called " diabetes ", and its Main Basis is " urinating sweet ", " glucose in urine " namely said now.What is more important, occur " three-many-one-little " (polydipsia, polyphagia, polyuria and become thin weak), the patient namely quenched one's thirst, only accounts for small part in diabetes patient, and nearly the patient of 80% does not occur " three-many-one-little " clinically.If diagnosed according to glucose in urine or appearance " three-many-one-little ", the state of an illness of most of diabetes patient can be incured loss through delay.
The traditional Chinese medical science is thought, the major lesions position of diabetes is at lung, stomach, kidney, and basic pathogenesis is cloudy body fluid deficiency consumption, scorching inclined Sheng.Diabetes with the passing of time, the state of an illness is out of control, then deficiency of YIN affecting YANG, the bright blood stasis due to loss of body fluid of heat, and cause impairment of both QI and YIN, deficiency in both YIN and YANG, channels stasis blocking, passages through which vital energy circulates loses supports, and QI and blood is inverse disorderly, internal organs impaired organ and occur, dizzy, the thoracic obstruction, deafness, blindness, limbs fiber crops pain, lower limb gangrene, the accompanied symptoms such as renal failure edema, apoplectic coma.
Although the method at present in treatment diabetes and medicine are a lot, there is drawback, not ideal enough.For example western medicine, though instant effect, cures the symptoms, not the disease, and easily repeatedly, long-term taking body produces drug resistance to the state of an illness, and toxic and side effects is large; Relative to the curative effect of hypoglycemic medicine in doctor trained in Western medicine, existing Chinese medicine side effect is little, but hypoglycemic effect is more weak, and large drug is single, and therapeutic domain is narrow, and onset is comparatively slow, and the course for the treatment of is very long.Other physiotherapy, acupuncture, food therapy etc. are also take effect very micro-or invalid, are not suitable for promotion and application.
Summary of the invention
The object of this invention is to provide a kind of Chinese medicine composition for the treatment of diabetes.
In order to realize object of the present invention, the invention provides a kind of Chinese medicine composition for the treatment of diabetes, it comprises the material of following weight portion: Radix Ginseng 10-15 part, Radix Astragali 1-40 part, Poria cum Radix Pini 10-20 part, Radix Glycyrrhizae 10-20 part, Radix Rehmanniae 20-30 part, Radix Trichosanthis 10-20 part, Radix Ophiopogonis 10-20 part, Rhizoma Anemarrhenae 10-20 part, Rhizoma Coptidis 5-10 part, Gypsum Fibrosum 15-25 part, Semen Cuscutae 10-20 part, Herba Cistanches 10-20 part, Semen Astragali Complanati 10-30 part, Rhizoma Dioscoreae 15-30 part, Fructus Corni 15-30 part, Endothelium Corneum Gigeriae Galli 15-25 part, Rhizoma Polygonati Odorati 10-20 part, Ganoderma 5-15 part, Herba Dendrobii 10-15 part, Radix Angelicae Sinensis 10-15 part, Fructus Lycii 10-20 part, Rhizoma Atractylodis 10-20 part, Radix Salviae Miltiorrhizae 10-20 part, Herba Leonuri 10-20 part, Fructus Rubi 10-20 part, Fructus Alpiniae Oxyphyllae 10-20 part, Radix Scrophulariae 15-25 part, Concha Ostreae 15-25 part, Rhizoma Polygonati 15-25 part, Semen Cassiae 15-25 part and Radix Et Rhizoma Rhei 8-12 part.
Preferably, the Chinese medicine composition for the treatment of diabetes of the present invention comprises the material of following weight portion: Radix Ginseng 12 parts, the Radix Astragali 20 parts, Poria cum Radix Pini 15 parts, 15 parts, Radix Glycyrrhizae, 25 parts, the Radix Rehmanniae, Radix Trichosanthis 15 parts, Radix Ophiopogonis 15 parts, the Rhizoma Anemarrhenae 15 parts, Rhizoma Coptidis 8 parts, 20 parts, Gypsum Fibrosum, Semen Cuscutae 15 parts, Herba Cistanches 15 parts, Semen Astragali Complanati 20 parts, Rhizoma Dioscoreae 25 parts, Fructus Corni 25 parts, Endothelium Corneum Gigeriae Galli 20 parts, Rhizoma Polygonati Odorati 15 parts, Ganoderma 10 parts, Herba Dendrobii 12 parts, Radix Angelicae Sinensis 12 parts, Fructus Lycii 15 parts, Rhizoma Atractylodis 15 parts, Radix Salviae Miltiorrhizae 15 parts, Herba Leonuri 15 parts, Fructus Rubi 15 parts, Fructus Alpiniae Oxyphyllae 15 parts, Radix Scrophulariae 20 parts, Concha Ostreae 20 parts, Rhizoma Polygonati 20 parts, Semen Cassiae 20 parts and Radix Et Rhizoma Rhei 10 parts.
More preferably, the Chinese medicine composition for the treatment of diabetes of the present invention also comprises the material of following weight portion: Radix Et Rhizoma Tylophorae Ovatae 18 parts, Caulis Bauhihiae Championii 16 parts, Oreas martiana (Hopp. Et Hornsch.) Brid. 15 parts, Cortex Linderae Obtusilobae 15 points, Rhizoma begoniae pedatifidae 13 parts, Herba penniseti 13 parts, Herba Saginae Japonicae 10 parts, Radix Oenotherae erythrosepalae 12 parts, Herba Adenostemmatis 10 parts and Radix Habenariae Dentatae 10 parts.
Most preferably, described Chinese medicine composition can be tablet, dispersible tablet, capsule, patch or decoction.
The present invention also provides the purposes of compositions in the Chinese medicine of preparation treatment diabetes, described compositions comprises the material of following weight portion: Radix Ginseng 10-15 part, Radix Astragali 1-40 part, Poria cum Radix Pini 10-20 part, Radix Glycyrrhizae 10-20 part, Radix Rehmanniae 20-30 part, Radix Trichosanthis 10-20 part, Radix Ophiopogonis 10-20 part, Rhizoma Anemarrhenae 10-20 part, Rhizoma Coptidis 5-10 part, Gypsum Fibrosum 15-25 part, Semen Cuscutae 10-20 part, Herba Cistanches 10-20 part, Semen Astragali Complanati 10-30 part, Rhizoma Dioscoreae 15-30 part, Fructus Corni 15-30 part, Endothelium Corneum Gigeriae Galli 15-25 part, Rhizoma Polygonati Odorati 10-20 part, Ganoderma 5-15 part, Herba Dendrobii 10-15 part, Radix Angelicae Sinensis 10-15 part, Fructus Lycii 10-20 part, Rhizoma Atractylodis 10-20 part, Radix Salviae Miltiorrhizae 10-20 part, Herba Leonuri 10-20 part, Fructus Rubi 10-20 part, Fructus Alpiniae Oxyphyllae 10-20 part, Radix Scrophulariae 15-25 part, Concha Ostreae 15-25 part, Rhizoma Polygonati 15-25 part, Semen Cassiae 15-25 part and Radix Et Rhizoma Rhei 8-12 part
Preferably, described compositions comprises the material of following weight portion: Radix Ginseng 12 parts, the Radix Astragali 20 parts, Poria cum Radix Pini 15 parts, 15 parts, Radix Glycyrrhizae, 25 parts, the Radix Rehmanniae, Radix Trichosanthis 15 parts, Radix Ophiopogonis 15 parts, the Rhizoma Anemarrhenae 15 parts, Rhizoma Coptidis 8 parts, 20 parts, Gypsum Fibrosum, Semen Cuscutae 15 parts, Herba Cistanches 15 parts, Semen Astragali Complanati 20 parts, Rhizoma Dioscoreae 25 parts, Fructus Corni 25 parts, Endothelium Corneum Gigeriae Galli 20 parts, Rhizoma Polygonati Odorati 15 parts, Ganoderma 10 parts, Herba Dendrobii 12 parts, Radix Angelicae Sinensis 12 parts, Fructus Lycii 15 parts, Rhizoma Atractylodis 15 parts, Radix Salviae Miltiorrhizae 15 parts, Herba Leonuri 15 parts, Fructus Rubi 15 parts, Fructus Alpiniae Oxyphyllae 15 parts, Radix Scrophulariae 20 parts, Concha Ostreae 20 parts, Rhizoma Polygonati 20 parts, Semen Cassiae 20 parts and Radix Et Rhizoma Rhei 10 parts.
More preferably, described compositions also comprises the material of following weight portion: Radix Et Rhizoma Tylophorae Ovatae 18 parts, Caulis Bauhihiae Championii 16 parts, Oreas martiana (Hopp. Et Hornsch.) Brid. 15 parts, Cortex Linderae Obtusilobae 15 points, Rhizoma begoniae pedatifidae 13 parts, Herba penniseti 13 parts, Herba Saginae Japonicae 10 parts, Radix Oenotherae erythrosepalae 12 parts, Herba Adenostemmatis 10 parts and Radix Habenariae Dentatae 10 parts.
Most preferably, described Chinese medicine can be tablet, dispersible tablet, capsule, patch or decoction.
Chinese medicine composition of the present invention interacts, and synergism is evident in efficacy, highly widelys popularize.
Detailed description of the invention
The present invention is further illustrated below by embodiment.It should be understood that embodiments of the invention are for illustration of the present invention instead of limitation of the present invention.Essence according to the present invention all belongs to the scope of protection of present invention to the simple modifications that the present invention carries out.Unless otherwise stated, the percent in the present invention is percetage by weight.
Embodiment 1 patch of the present invention
Take Radix Ginseng 120 grams, the Radix Astragali 200 grams, Poria cum Radix Pini 150 grams, 150 grams, Radix Glycyrrhizae, 250 grams, the Radix Rehmanniae, Radix Trichosanthis 150 grams, Radix Ophiopogonis 150 grams, the Rhizoma Anemarrhenae 150 grams, Rhizoma Coptidis 80 grams, 200 grams, Gypsum Fibrosum, Semen Cuscutae 150 grams, Herba Cistanches 150 grams, Semen Astragali Complanati 200 grams, Rhizoma Dioscoreae 250 grams, Fructus Corni 250 grams, Endothelium Corneum Gigeriae Galli 200 grams, Rhizoma Polygonati Odorati 150 grams, Ganoderma 100 grams, Herba Dendrobii 120 grams, Radix Angelicae Sinensis 120 grams, Fructus Lycii 150 grams, Rhizoma Atractylodis 150 grams, Radix Salviae Miltiorrhizae 150 grams, Herba Leonuri 150 grams, Fructus Rubi 150 grams, Fructus Alpiniae Oxyphyllae 150 grams, Radix Scrophulariae 200 grams, Concha Ostreae 200 grams, Rhizoma Polygonati 200 grams, Semen Cassiae 200 grams and Radix Et Rhizoma Rhei 100 grams, pulverize, cross 60 mesh sieves, add 800 grams, vaseline and lanoline 800 grams, stir, uniform application is on aseptic non-woven fabrics, evenly be cut into 1000 pieces, every block length is wide is 6cm, thickness is 1cm.
Embodiment 2 patch of the present invention
Take Radix Ginseng 120 grams, the Radix Astragali 200 grams, Poria cum Radix Pini 150 grams, 150 grams, Radix Glycyrrhizae, 250 grams, the Radix Rehmanniae, Radix Trichosanthis 150 grams, Radix Ophiopogonis 150 grams, the Rhizoma Anemarrhenae 150 grams, Rhizoma Coptidis 80 grams, 200 grams, Gypsum Fibrosum, Semen Cuscutae 150 grams, Herba Cistanches 150 grams, Semen Astragali Complanati 200 grams, Rhizoma Dioscoreae 250 grams, Fructus Corni 250 grams, Endothelium Corneum Gigeriae Galli 200 grams, Rhizoma Polygonati Odorati 150 grams, Ganoderma 100 grams, Herba Dendrobii 120 grams, Radix Angelicae Sinensis 120 grams, Fructus Lycii 150 grams, Rhizoma Atractylodis 150 grams, Radix Salviae Miltiorrhizae 150 grams, Herba Leonuri 150 grams, Fructus Rubi 150 grams, Fructus Alpiniae Oxyphyllae 150 grams, Radix Scrophulariae 200 grams, Concha Ostreae 200 grams, Rhizoma Polygonati 200 grams, Semen Cassiae 200 grams, Radix Et Rhizoma Rhei 100 grams, Radix Et Rhizoma Tylophorae Ovatae 180 grams, Caulis Bauhihiae Championii 160 grams, Oreas martiana (Hopp. Et Hornsch.) Brid. 150 grams, Cortex Linderae Obtusilobae 15 points, Rhizoma begoniae pedatifidae 130 grams, Herba penniseti 130 grams, Herba Saginae Japonicae 100 grams, Radix Oenotherae erythrosepalae 120 grams, Herba Adenostemmatis 100 grams and Radix Habenariae Dentatae 100 grams, pulverize, and crosses 60 mesh sieves, and add 800 grams, vaseline and lanoline 800 grams, stir, uniform application, on aseptic non-woven fabrics, is evenly cut into 1000 pieces, and every block length is wide is 6cm, and thickness is 1cm.
Experimental example
Diagnostic criteria:
Western medicine diagnose standard:
There is diabetic symptom (polyuria, polydipsia and inexplicable weight loss), and random (any time after the meal) plasma glucose (VPG) >=11.1mmol/L (200mg/dl); Or (taboo energy intake at least 8h) plasma glucose (FPG) >=7.0mmol/L (126mg/dl) on an empty stomach; Or 75g anhydroglucose is soluble in water) plasma glucose (the 2hPG) >=11.1mmol/L (200mg/dl) of 2 hours.
Standards of Chinese Medical Syndrome Differentiation: according to " TCM Differentiation of Clinical Stages of diabetes (diabetes) and the standard of curative effect evaluation " of the revision of diabetes (diabetes) Professional Committee of China Association of Traditional Chinese Medicine, with reference to the Standards of Chinese Medical Syndrome Differentiation of " diabetes " " hyperlipemia " " hypertension " part in " new Chinese medicine guideline of clinical investigations ", Chinese medical discrimination is syndrome of liver-stomach heat, type of deficiency of both QI and YIN.
1.2 Excluded cases standards:
(1) actute infection person is associated with;
(2) acute coronary syndrome person;
(3) Acute Cerebrovascular Diseases person;
(4) serious hepatic and kidney function obstacle person;
(5) blood pressure > 160/100mmHg or FPG > 11.1mmol/L or after the meal 2 hours blood glucoses (2hPG) > 16.7mmol/L or TG > 5.7mmol/L person;
(6) be associated with other serious diseases and should not accept this therapist;
(7) person that takes Thiazolidinediones;
(8) noncooperationist.
Inclusive criteria: all diagnostic criterias meeting diabetes, Chinese medical discrimination is syndrome of liver-stomach heat, type of deficiency of both QI and YIN.
Selector close state diagnostic criteria diabetics 100 example, be divided into 2 groups, first group 50 example, wherein man 28 example, female 22 example, the age (55 ± 8) year, diabetic duration 1-3; Second group 50 example, wherein man 27 example, female 23 example, the age (54 ± 7) year, diabetic duration 1-3.Two groups sex, the age, the course of disease, etc. in compare there was no significant difference (P > 0.05), there is comparability.
2 groups of patients all carry out health education in diabetes, diabetic diet and appropriate exercise.First group of patient uses the patch of preparation in embodiment 1 to treat, and every day 3 times, is attached on the umbilicus of patient by 1 piece of patch at every turn, continuously treatment 3 months.Second group of patient uses the patch of preparation in embodiment 2 to treat, and every day 3 times, is attached on the umbilicus of patient by 1 piece of patch at every turn, continuously treatment 3 months
Testing index
Detect 2 groups in the viewing duration fasting glucose of every 2 weeks (FBG), after the meal 2 hours blood glucoses (2-hPPG), HbAlc, hypoglycemia incidence rate, body weight change situation.
Statistical procedures
Measurement data mean ± standard deviation represents, compares and adopts t inspection, use SPSS 12.0 statistics software between group, and P < 0.05 has significant difference for statistics.
Result
Second group is better than first group (P < 0.05) in glycemic control; Be better than first group (P < 0.05) in reduction HbAlc; Second group is better than first group (P < 0.05) in the risk reducing hypoglycemia and body weight increase.See the following form, wherein the first row is the data of first group of front 50 routine patient for the treatment of, and the second row is the data of 50 routine patients after first group for the treatment of, and the third line is the data of second group of front 50 routine patient for the treatment of, and fourth line is the data of 50 routine patients after second group for the treatment of.
Observe in the treatment, do not occur serious adverse reaction, treat the blood of two groups of patients after terminating, urine, stool routine and hepatic and renal function inspection and be showed no exception.
Claims (8)
1. treat the Chinese medicine composition of diabetes for one kind, it is characterized in that, it comprises the material of following weight portion: Radix Ginseng 10-15 part, Radix Astragali 1-40 part, Poria cum Radix Pini 10-20 part, Radix Glycyrrhizae 10-20 part, Radix Rehmanniae 20-30 part, Radix Trichosanthis 10-20 part, Radix Ophiopogonis 10-20 part, Rhizoma Anemarrhenae 10-20 part, Rhizoma Coptidis 5-10 part, Gypsum Fibrosum 15-25 part, Semen Cuscutae 10-20 part, Herba Cistanches 10-20 part, Semen Astragali Complanati 10-30 part, Rhizoma Dioscoreae 15-30 part, Fructus Corni 15-30 part, Endothelium Corneum Gigeriae Galli 15-25 part, Rhizoma Polygonati Odorati 10-20 part, Ganoderma 5-15 part, Herba Dendrobii 10-15 part, Radix Angelicae Sinensis 10-15 part, Fructus Lycii 10-20 part, Rhizoma Atractylodis 10-20 part, Radix Salviae Miltiorrhizae 10-20 part, Herba Leonuri 10-20 part, Fructus Rubi 10-20 part, Fructus Alpiniae Oxyphyllae 10-20 part, Radix Scrophulariae 15-25 part, Concha Ostreae 15-25 part, Rhizoma Polygonati 15-25 part, Semen Cassiae 15-25 part and Radix Et Rhizoma Rhei 8-12 part.
2. the Chinese medicine composition for the treatment of diabetes according to claim 1, it is characterized in that, it comprises the material of following weight portion: Radix Ginseng 12 parts, the Radix Astragali 20 parts, Poria cum Radix Pini 15 parts, 15 parts, Radix Glycyrrhizae, 25 parts, the Radix Rehmanniae, Radix Trichosanthis 15 parts, Radix Ophiopogonis 15 parts, the Rhizoma Anemarrhenae 15 parts, Rhizoma Coptidis 8 parts, 20 parts, Gypsum Fibrosum, Semen Cuscutae 15 parts, Herba Cistanches 15 parts, Semen Astragali Complanati 20 parts, Rhizoma Dioscoreae 25 parts, Fructus Corni 25 parts, Endothelium Corneum Gigeriae Galli 20 parts, Rhizoma Polygonati Odorati 15 parts, Ganoderma 10 parts, Herba Dendrobii 12 parts, Radix Angelicae Sinensis 12 parts, Fructus Lycii 15 parts, Rhizoma Atractylodis 15 parts, Radix Salviae Miltiorrhizae 15 parts, Herba Leonuri 15 parts, Fructus Rubi 15 parts, Fructus Alpiniae Oxyphyllae 15 parts, Radix Scrophulariae 20 parts, Concha Ostreae 20 parts, Rhizoma Polygonati 20 parts, Semen Cassiae 20 parts and Radix Et Rhizoma Rhei 10 parts.
3. the Chinese medicine composition for the treatment of diabetes according to claim 1 and 2, it is characterized in that, it also comprises the material of following weight portion: Radix Et Rhizoma Tylophorae Ovatae 18 parts, Caulis Bauhihiae Championii 16 parts, Oreas martiana (Hopp. Et Hornsch.) Brid. 15 parts, Cortex Linderae Obtusilobae 15 points, Rhizoma begoniae pedatifidae 13 parts, Herba penniseti 13 parts, Herba Saginae Japonicae 10 parts, Radix Oenotherae erythrosepalae 12 parts, Herba Adenostemmatis 10 parts and Radix Habenariae Dentatae 10 parts.
4. the Chinese medicine composition for the treatment of diabetes according to claim 3, is characterized in that, described Chinese medicine composition can be tablet, dispersible tablet, capsule, patch or decoction.
5. the purposes of compositions in the Chinese medicine of preparation treatment diabetes, it is characterized in that, described compositions comprises the material of following weight portion: Radix Ginseng 10-15 part, Radix Astragali 1-40 part, Poria cum Radix Pini 10-20 part, Radix Glycyrrhizae 10-20 part, Radix Rehmanniae 20-30 part, Radix Trichosanthis 10-20 part, Radix Ophiopogonis 10-20 part, Rhizoma Anemarrhenae 10-20 part, Rhizoma Coptidis 5-10 part, Gypsum Fibrosum 15-25 part, Semen Cuscutae 10-20 part, Herba Cistanches 10-20 part, Semen Astragali Complanati 10-30 part, Rhizoma Dioscoreae 15-30 part, Fructus Corni 15-30 part, Endothelium Corneum Gigeriae Galli 15-25 part, Rhizoma Polygonati Odorati 10-20 part, Ganoderma 5-15 part, Herba Dendrobii 10-15 part, Radix Angelicae Sinensis 10-15 part, Fructus Lycii 10-20 part, Rhizoma Atractylodis 10-20 part, Radix Salviae Miltiorrhizae 10-20 part, Herba Leonuri 10-20 part, Fructus Rubi 10-20 part, Fructus Alpiniae Oxyphyllae 10-20 part, Radix Scrophulariae 15-25 part, Concha Ostreae 15-25 part, Rhizoma Polygonati 15-25 part, Semen Cassiae 15-25 part and Radix Et Rhizoma Rhei 8-12 part.
6. purposes according to claim 5, it is characterized in that, described compositions comprises the material of following weight portion: Radix Ginseng 12 parts, the Radix Astragali 20 parts, Poria cum Radix Pini 15 parts, 15 parts, Radix Glycyrrhizae, 25 parts, the Radix Rehmanniae, Radix Trichosanthis 15 parts, Radix Ophiopogonis 15 parts, the Rhizoma Anemarrhenae 15 parts, Rhizoma Coptidis 8 parts, 20 parts, Gypsum Fibrosum, Semen Cuscutae 15 parts, Herba Cistanches 15 parts, Semen Astragali Complanati 20 parts, Rhizoma Dioscoreae 25 parts, Fructus Corni 25 parts, Endothelium Corneum Gigeriae Galli 20 parts, Rhizoma Polygonati Odorati 15 parts, Ganoderma 10 parts, Herba Dendrobii 12 parts, Radix Angelicae Sinensis 12 parts, Fructus Lycii 15 parts, Rhizoma Atractylodis 15 parts, Radix Salviae Miltiorrhizae 15 parts, Herba Leonuri 15 parts, Fructus Rubi 15 parts, Fructus Alpiniae Oxyphyllae 15 parts, Radix Scrophulariae 20 parts, Concha Ostreae 20 parts, Rhizoma Polygonati 20 parts, Semen Cassiae 20 parts and Radix Et Rhizoma Rhei 10 parts.
7. the purposes according to claim 5 or 6, it is characterized in that, described compositions also comprises the material of following weight portion: Radix Et Rhizoma Tylophorae Ovatae 18 parts, Caulis Bauhihiae Championii 16 parts, Oreas martiana (Hopp. Et Hornsch.) Brid. 15 parts, Cortex Linderae Obtusilobae 15 points, Rhizoma begoniae pedatifidae 13 parts, Herba penniseti 13 parts, Herba Saginae Japonicae 10 parts, Radix Oenotherae erythrosepalae 12 parts, Herba Adenostemmatis 10 parts and Radix Habenariae Dentatae 10 parts.
8. purposes according to claim 7, is characterized in that, described Chinese medicine can be tablet, dispersible tablet, capsule, patch or decoction.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510536398.5A CN104998176A (en) | 2015-08-28 | 2015-08-28 | Traditional Chinese medicine composition for treating diabetes |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510536398.5A CN104998176A (en) | 2015-08-28 | 2015-08-28 | Traditional Chinese medicine composition for treating diabetes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104998176A true CN104998176A (en) | 2015-10-28 |
Family
ID=54371212
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510536398.5A Pending CN104998176A (en) | 2015-08-28 | 2015-08-28 | Traditional Chinese medicine composition for treating diabetes |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104998176A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106491990A (en) * | 2016-12-05 | 2017-03-15 | 童守信 | A kind of Chinese medicine composition for treating diabetes B |
| CN109157615A (en) * | 2018-08-13 | 2019-01-08 | 李阳 | It is a kind of to treat diabetes Chinese prescription |
| CN111012881A (en) * | 2019-12-27 | 2020-04-17 | 张为举 | Chinese medicinal preparation for treating diabetes and its complications and preparation method thereof |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101049440A (en) * | 2006-04-03 | 2007-10-10 | 北京因科瑞斯生物制品研究所 | Preparation of Chinese traditional medicine in use for diabetes, and preparation method |
| CN103893547A (en) * | 2014-04-09 | 2014-07-02 | 李建明 | Traditional Chinese medicinal composition for treating diabetes mellitus |
-
2015
- 2015-08-28 CN CN201510536398.5A patent/CN104998176A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101049440A (en) * | 2006-04-03 | 2007-10-10 | 北京因科瑞斯生物制品研究所 | Preparation of Chinese traditional medicine in use for diabetes, and preparation method |
| CN103893547A (en) * | 2014-04-09 | 2014-07-02 | 李建明 | Traditional Chinese medicinal composition for treating diabetes mellitus |
Non-Patent Citations (2)
| Title |
|---|
| 张年顺主编: "《生活中的9000个实用名方偏方》", 31 January 2009, 农村读物出版社 * |
| 钱超尘等主编: "《孙思邈研究集成》", 31 January 2006, 中医古籍出版社 * |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106491990A (en) * | 2016-12-05 | 2017-03-15 | 童守信 | A kind of Chinese medicine composition for treating diabetes B |
| CN106491990B (en) * | 2016-12-05 | 2019-09-03 | 童守信 | A kind of Chinese medicine composition for treating diabetes B |
| CN109157615A (en) * | 2018-08-13 | 2019-01-08 | 李阳 | It is a kind of to treat diabetes Chinese prescription |
| CN111012881A (en) * | 2019-12-27 | 2020-04-17 | 张为举 | Chinese medicinal preparation for treating diabetes and its complications and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101757403B (en) | Traditional Chinese medicine composition for treating acute nephritis and preparation method thereof | |
| CN103893547A (en) | Traditional Chinese medicinal composition for treating diabetes mellitus | |
| CN103860699B (en) | A kind of pharmaceutical composition for effecting a radical cure three-hypers | |
| CN104352776A (en) | Traditional Chinese medicine preparation for treating infertility caused by hypomenorrhea and preparation method thereof | |
| CN101716298B (en) | Traditional Chinese medicine preparation for treating surgical intestinal adhesions | |
| CN102488743B (en) | Chinese traditional medicine composition, preparation method thereof and Chinese traditional medicine preparation | |
| CN101234164A (en) | Pharmaceutical combination for improving skin oil-water balance and acne symptom and preparation thereof | |
| CN104998176A (en) | Traditional Chinese medicine composition for treating diabetes | |
| CN105125851A (en) | Traditional Chinese medicine treating 2-type diabetes and preparation technology | |
| CN104001035A (en) | Trichosanthis Radix and Radix Puerariae-containing traditional Chinese medicinal preparation for treating type 2 diabetes mellitus | |
| CN103623292A (en) | Traditional Chinese medicine composition for treating diabetes mellitus | |
| CN102698098B (en) | Traditional Chinese medicine for treating diabetes mellitus | |
| CN102343026B (en) | Traditional Chinese medicine composition for treating diabetes and preparation method thereof | |
| CN102688445B (en) | Traditional Chinese medicine for treating diabetes and preparation method thereof | |
| CN103463566B (en) | Traditional Chinese medicine composition for treating chronic bronchitis | |
| CN103006989B (en) | Medical composition for treating diabetic nephropathy | |
| CN102600426A (en) | Chinese medicinal preparation for promoting blood circulation to remove blood stasis and preparation method thereof | |
| CN103585591A (en) | Traditional Chinese medicine for treating gallstones | |
| CN103251864A (en) | Chinese medicament for treating pneumonia and preparation method thereof | |
| CN102671160B (en) | Traditional Chinese medicine decoction for treating edema and preparation method of traditional Chinese medicine decoction | |
| CN103638389A (en) | Traditional Chinese medicine composition for treating diabetes | |
| CN101406681B (en) | Chinese medicinal toxin-expelling decoction for uraemia | |
| CN104162043A (en) | Traditional Chinese medicine used for treatment of allergic nodular cutaneous vasculitis | |
| CN104771691A (en) | Traditional Chinese medicine composition for treating diabetes | |
| CN104367753A (en) | Traditional Chinese medicine composition for treating type 2 diabetes |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20151028 |